Proton magnetic resonance spectroscopy of a boron neutron capture therapy 10B-carrier, L-p-boronophenylalanine-fructose complex

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Unknown venue

• Publication date

  2010-01-22

• Fields of study

  Medicine, Chemistry

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• P-31 magnetic resonance spectroscopy. A tool for diagnostic purposes and pathophysiological insights in muscle diseases.

  2011cited by this paper
• Finnish Dosimetric Practice for Epithermal Neutron Beam Dosimetry in Boron Neutron Capture Therapy

  2009cited by this paper
• In vivo 19F MR imaging and spectroscopy for the BNCT optimization.

  2009cited by this paper
• Current and Potential Applications of Clinical 13C MR Spectroscopy

  2008cited by this paper
• Evaluation of extra‐ and intracellular apparent diffusion coefficient of sodium in rat skeletal muscle: Effects of prolonged ischemia

  2008cited by this paper
• boronophenylalanine-fructose complex on a C6 rat glioma model to optimize boron neutron capture therapy (BNCT)

  2008cited by this paper
• Boron detection from blood samples by ICP‐AES and ICP‐MS during boron neutron capture therapy

  2008cited by this paper
• In vivo 19F MRI and 19F MRS of 19F-labelled boronophenylalanine–fructose complex on a C6 rat glioma model to optimize boron neutron capture therapy (BNCT)

  2008cited by this paper
• Assessment of in vivo 1H magnetic resonance spectroscopy in the liver: a review

  2008cited by this paper
• Uptake of two 10B‐compounds in liver metastases of colorectal adenocarcinoma for extracorporeal irradiation with boron neutron capture therapy (EORTC Trial 11001)

  2007cited by this paper
• Quantitative 19F MR spectroscopy at 3 T to detect heterogeneous capecitabine metabolism in human liver

  2007cited by this paper
• Early effects of boron neutron capture therapy on rat glioma models

  2007cited by this paper
• Boron neutron capture therapy in the treatment of locally recurred head and neck cancer.

  2007cited by this paper
• In vivo19F Magnetic Resonance Spectroscopy and Chemical Shift Imaging of Tri-Fluoro-Nitroimidazole as a Potential Hypoxia Reporter in Solid Tumors

  2007cited by this paper
• Adaptive tree multigrids and simplified spherical harmonics approximation in deterministic neutral and charged particle transport

  2007cited by this paper
• Cardiac magnetic resonance spectroscopy: a window for studying physiology.

  2006cited by this paper
• Role of proton MR for the study of muscle lipid metabolism

  2006cited by this paper
• First clinical case of boron neutron capture therapy for head and neck malignancies using 18F‐BPA PET

  2006cited by this paper
• Noninvasive Quantitative In Vivo Mapping and Metabolism of Boronophenylalanine (BPA) by Nuclear Magnetic Resonance (NMR) Spectroscopy and Imaging

  2005cited by this paper
• Hepatic 31P magnetic resonance spectroscopy: a hepatologist's user guide

  2005cited by this paper
• Spin-echo MRS in humans at high field: LASER localisation using FOCI pulses.

  2005cited by this paper
• Distribution of BPA and metabolic assessment in glioblastoma patients during BNCT treatment: a microdialysis study

  2005cited by this paper
• Efficacy of proton magnetic resonance spectroscopy in neurological diagnosis and neurotherapeutic decision making

  2005cited by this paper
• Optimized 1H MRS and MRSI methods for the in vivo detection of boronophenylalanine

  2005cited by this paper
• Effectiveness of BNCT for recurrent head and neck malignancies.

  2004cited by this paper
• A reduced cerebral metabolic ratio in exercise reflects metabolism and not accumulation of lactate within the human brain

  2004cited by this paper
• Enhanced blood boron concentration estimation for BPA-F mediated BNCT.

  2004cited by this paper
• Evaluation of 4-borono-2-18F-fluoro-L-phenylalanine-fructose as a probe for boron neutron capture therapy in a glioma-bearing rat model.

  2004cited by this paper
• Undifferentiated sinonasal carcinoma may respond to single-fraction boron neutron capture therapy.

  2004cited by this paper
• Boron neutron capture therapy of brain tumors: clinical trials at the Finnish facility using boronophenylalanine

  2003influential reference
• Parallel spectroscopic imaging with spin‐echo trains

  2003cited by this paper
• Boron concentrations in brain during boron neutron capture therapy: in vivo measurements from the phase I trial EORTC 11961 using a gamma-ray telescope.

  2003cited by this paper
• Generalized autocalibrating partially parallel acquisitions (GRAPPA)

  2002cited by this paper
• FiR 1 epithermal neutron beam model and dose calculation for treatment planning in neutron capture therapy

  2002cited by this paper
• Improved treatment planning for boron neutron capture therapy for glioblastoma multiforme using fluorine-18 labeled boronophenylalanine and positron emission tomography.

  2002cited by this paper
• Double Resonance NMR Imaging of BSH

  2002cited by this paper
• Solutions for clinical implementation of boron neutron capture therapy in Finland

  2002cited by this paper
• Proton T 1 and T 2 relaxation times of human brain metabolites at 3 Tesla

  2001cited by this paper
• Sensitivity‐encoded spectroscopic imaging

  2001cited by this paper
• Toward clinical application of prompt gamma spectroscopy for in vivo monitoring of boron uptake in boron neutron capture therapy.

  2001cited by this paper
• The return of the frequency sweep: designing adiabatic pulses for contemporary NMR.

  2001cited by this paper
• Magnetic resonance spectroscopy of the human brain

  2001cited by this paper
• Validation of the scanning -gamma-ray telescope for in vivo dosimetry and boron measurements during BNCT.

  2001cited by this paper
• Effects of k-space filtering and image interpolation on image fidelity in (1)H MRSI.

  2001cited by this paper
• Atomic emission method for total boron in blood during neutron-capture therapy.

  2001cited by this paper
• Optimal detection of the neutron capture therapy agent borocaptate sodium (BSH): a comparison between 1H and 10B NMR.

  2001cited by this paper
• Accurate phosphorus metabolite images of the human heart by 3D acquisition‐weighted CSI

  2001cited by this paper
• Boron neutron capture therapy for malignant gliomas

  2000cited by this paper
• The virtual NMR spectrometer: a computer program for efficient simulation of NMR experiments involving pulsed field gradients.

  2000cited by this paper
• Studies on the structure of the complex of the boron neutron capture therapy drug, L-p-boronophenylalanine, with fructose and related carbohydrates: chemical and 13C NMR evidence for the beta-D-fructofuranose 2,3,6-(p-phenylalanylorthoboronate) structure.

  2000cited by this paper
• SENSE: Sensitivity encoding for fast MRI

  1999cited by this paper
• Proton nuclear magnetic resonance measurement of p-boronophenylalanine (BPA): a therapeutic agent for boron neutron capture therapy.

  1999cited by this paper
• The radiation biology of boron neutron capture therapy.

  1999cited by this paper
• Metrology and quality of radiation therapy dosimetry of electron, photon and epithermal neutron beams

  1999cited by this paper
• Magnetic Resonance Spectroscopy Diagnosis of Neurological Diseases

  1999influential reference
• Biodistribution of p-boronophenylalanine in patients with glioblastoma multiforme for use in boron neutron capture therapy.

  1998cited by this paper
• Positron emission tomography-based boron neutron capture therapy using boronophenylalanine for high-grade gliomas: part II.

  1998cited by this paper
• Fluorine-18-labeled fluoroboronophenylalanine PET in patients with glioma.

  1998cited by this paper
• Proton NMR spectroscopy of solvent‐saturable resonances: A new approach to study pH effects in Situ

  1998cited by this paper
• Differentiation of metabolic concentrations between gray matter and white matter of human brain by in vivo 1H magnetic resonance spectroscopy

  1998cited by this paper
• Regional metabolite concentrations in human brain as determined by quantitative localized proton MRS

  1998cited by this paper
• Biodistribution of boronophenylalanine in patients with glioblastoma multiforme: boron concentration correlates with tumor cellularity.

  1998cited by this paper
• Quantitative spectroscopic imaging of the human brain

  1998cited by this paper
• Lack of effect of oral choline supplement on the concentrations of choline metabolites in human brain

  1998cited by this paper
• The role of boron MRI in boron neutron capture therapy

  1997cited by this paper
• Enhanced survival of glioma bearing rats following boron neutron capture therapy with blood-brain barrier disruption and intracarotid injection of boronophenylalanine

  1997cited by this paper
• Homocarnosine and the measurement of neuronal pH in patients with epilepsy

  1997cited by this paper
• Comparison of k‐space sampling schemes for multidimensional MR spectroscopic imaging

  1996cited by this paper
• Identification and quantitation of phenylalanine in the brain of patients with phenylketonuria by means of localized in vivo 1H magnetic-resonance spectroscopy.

  1995cited by this paper
• Three-dimensional echo-planar MR spectroscopic imaging at short echo times in the human brain.

  1994cited by this paper
• Evaluation of cerebral gray and white matter metabolite differences by spectroscopic imaging at 4.1T

  1994cited by this paper
• Reduced phase encoding in spectroscopic imaging

  1994cited by this paper
• Fast proton spectroscopic imaging of human brain using multiple spin‐echoes

  1993cited by this paper
• Estimation of metabolite concentrations from localized in vivo proton NMR spectra

  1993cited by this paper
• Sensitivity and localization enhancement in multinuclear in vivo NMR spectroscopy by outer volume presaturation

  1993cited by this paper
• Spectral localization with optimal pointspread function

  1991cited by this paper
• Improvement of solubility of p-boronophenylalanine by complex formation with monosaccharides.

  1989cited by this paper
• Localized proton NMR spectroscopy in different regions of the human brain in vivo. Relaxation times and concentrations of cerebral metabolites

  1989cited by this paper
• Complex formation of p-boronophenylalanine with some monosaccharides.

  1989cited by this paper
• SLIM: Spectral localization by imaging

  1988cited by this paper
• Spatial Localization in NMR Spectroscopy in Vivo

  1987cited by this paper
• Localized proton spectroscopy using stimulated echoes.

  1987cited by this paper
• Image-selected in Vivo spectroscopy (ISIS). A new technique for spatially selective nmr spectroscopy

  1986cited by this paper
• Neurometabolic effects of an inborn error of amino acid metabolism demonstrated in vivo by 1H NMR

  1986cited by this paper
• Proton nuclear magnetic resonance spectra of excised rat brain. Assignment of resonances.

  1985cited by this paper
• 1H NMR chemical shift selective (CHESS) imaging.

  1985cited by this paper
• Chemical‐Shift Imaging

  1985cited by this paper
• Spatially resolved high resolution spectroscopy by “four-dimensional” NMR

  1983cited by this paper
• Spatial mapping of the chemical shift in NMR

  1983cited by this paper
• NMR chemical shift imaging in three dimensions.

  1982cited by this paper
• Dynamic range problem in Fourier transform NMR. Modified WEFT pulse sequence

  1976cited by this paper
• Driven equilibrium Fourier transform spectroscopy. A new method for nuclear magnetic resonance signal enhancement.

  1969cited by this paper

• Boron neutron capture therapy (BNCT) in Finland: technological and physical prospects after 20 years of experiences.

  2013influential citation
• Dosimetry and dose planning in boron neutron capture therapy : Monte Carlo studies

  2012cites this paper